It’s a simple thing we encounter many times every single week – often while in a hurry. You pull up at a parking spot, scan a QR code and pay within seconds. Or you sit down at a cafe, scan a code to ...

Companies are scrambling to deal with the glut. Credit...Mojo Wang Supported by By Mike Isaac and Erin Griffith Reporting from San Francisco When a financial services company recently began using ...

Scientists have created a microscopic QR code so tiny it can only be seen with an electron microscope—smaller than most bacteria and now officially a world record. But this isn’t just about size; it’s ...

Coders have had a field day weeding through the treasures in the Claude Code leak. "It has turned into a massive sharing party," said Sigrid Jin, who created the Python edition, Claw Code. Here's how ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Just how small can a QR code be? Small enough that it can only be recognized with an electron microscope. A research team at TU Wien, working together with the data storage technology company Cerabyte ...

Spotify's CEO says the company's best developers are exclusively using AI to write code. Gustav Söderström said AI generates the code and the engineers "supervise" it. Some engineers have said ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...